In myotubes in vitro, the silencing of Hsp90 or STAT3 protects from the atrophy induced by C26 cancer cell conditional media (C26‐CM) and decreases the expression of Atrogin‐1, Myostatin and MuRF1. This evidence concerns the gene FBXO32 and cancer.